Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma
about
T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and OpportunitiesBisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancerNovel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.Associations of polymorphisms in NAT2 gene with risk and metastasis of osteosarcoma in young Chinese population.Association of polymorphisms in WWOX gene with risk and outcome of osteosarcoma in a sample of the young Chinese populationDecitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromesCelastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors.Combination therapy with L-arginine and α-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice.Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activationDecitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression.Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates.NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL-NKG2D Axis.
P2860
Q28074619-0D04BC58-19EB-4C04-8E52-8AC42B317B89Q33739857-A539935A-5C73-4A79-8528-CB7A65EF597EQ35550108-B36ABD96-53D7-4127-8FE5-A8CF04E538DAQ36111703-4FA67612-DCD9-47BE-9117-3861905AB9EAQ36617767-F9B35B69-E9C0-4432-9368-46AFEFD45AF7Q37685237-437F306C-673F-4646-98B8-2B987096A517Q37708954-6CD46778-5341-45DE-94E3-FDD192B59847Q40398428-6A2E2551-474C-461D-B356-B0071B5C78A7Q40432298-CF73C6DE-2172-424A-9A8C-5131E2CE0084Q41914210-98A7289F-09D0-435F-865E-3840AC9F2E2EQ52597632-B7C18193-BC99-40E1-99E5-6778E68A6116Q52657143-CA323A02-6E2B-4699-9C8E-C07A73F453B9Q54945263-C608D146-E10D-4609-BBF7-451DA9CA5B60Q55279130-FD94ECAA-852E-4898-859A-95B52EE3B184
P2860
Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@ast
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@en
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@nl
type
label
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@ast
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@en
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@nl
prefLabel
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@ast
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@en
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@nl
P2093
P2860
P356
P1433
P1476
Induction of a specific CD8+ T ...... treatment against osteosarcoma
@en
P2093
Binghao Li
Hengyuan Li
Jian Zhang
Lingling Sun
Xiaobing Zhu
Zhaoming Ye
P2860
P304
10791-10802
P356
10.18632/ONCOTARGET.2505
P407
P577
2014-11-01T00:00:00Z